CXCL10 and COVID-19: Consistent with this, the reported COVID-19-induced disruptions in gut microbial function were associated with disease severity and the inflammatory response, including elevated levels of pro-inflammatory cytokines and CXCL-10, a chemokine characteristic of COVID-19 [47,48].